Skip to main content

Table 3 Treatment-related toxicity

From: Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study

Treatment-related toxicity Grade 0-1 Grade 2 Grade 3 Grade 4 Grade 5
Acute toxicity      
Lung 67 (98.5%) 1 (1.5%) 0 0 0
Esophagus 29 (42.7%) 21 (30.9%) 18 (26.4%) 0 0
Skin 67 (98.5%) 0 1 (1.5%) 0 0
Hematologic      
  Hemoglobin 60 (88.2%) 3 (4.4%) 4 (5.9%) 1 (1.5%) 0
  Leucopenia 20 (29.4%) 26 (38.2%) 20 (29.4%) 2 (2.9%) 0
  Neutropenia 53 (77.9%) 3 (4.4%) 12 (17.7%) 0 0
  Thrombocytopenia 48 (70.6%) 13 (19.1%) 5 (7.4%) 2 (2.9%) 0
Gastrointestinal 57 (83.8%) 9 (13.2%) 2 (2.9%) 0 0
Late toxicity      
Lung 64 (94.1%) 3 (4.4%) 1 (1.5%) 0 0
Esophagus 61 (89.7%) 4 (5.9%) 1 (1.5%) 0 2 (2.9%)
Heart 66 (97.1%) 2 (2.9%) 0 0 0